FDA Approves First Gene Remedy for Hemophilia A
The US Meals and Drug Administration accredited the gene remedy valoctocogene roxaparvovec (Roctavian, BioMarin) for adults with extreme hemophilia A....
Hemophilia
Sanofi’s FDA Nod in Hemophilia Offers Sufferers Extra Comfort, Brings Roche New Competitors
Hemophilia A sufferers handle the persistent dysfunction with infusions administered as ceaselessly as each two to a few days. The...
